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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌto 
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation  
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3 Population and Healthcare Overview 
The population of Spain is 46,572,028 (World Bank, 2018a) and birth rate is estimated at 8.7 
births/1,000 population in 2016 (World Bank, 2018b).The change in population and birth 
rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Spain has a reported population density of 93 people per square kilometre in 2017 and this 
has risen from 62 people per square kilometre in 1961 (World Bank, 2018c). In terms of 
healthcare facilities, the total density of hospitals in 2013 was 1.63 per 100,000 population 
(WHO, 2016a). Infant mortality in 2017 is estimated at 2.6 deaths/1,000 live births in total 
(World Bank, 2018d). 
The average life expectancy in Spain is estimated at 82.8 years (World Bank, 2018e), with a 
death rate of 8.8 deaths/1,000 population in 2016 (World Bank, 2018f). Spain has a gross 
national income per capita (PPP int. $, 2013) of $31,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $2,966 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 9.0% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Spain between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
 
Summary Vision Screening Data: Spain                                                                                                   WP3 
 
3 
 
4 Vision Screening Commissioning and Guidance 
In Spain, vision screening is organised nationally, with no regional variation. All regions 
perform vision screening as part of a general preventative child healthcare screening system. 
Despite this national programme it is known that some rural areas do not perform all the 
vision screening tests and there are many differences between regional funding in Spain. 
Pupillary reflexes and cover tests are always done, but visual acuity is not. Vision screening is 
funded by the state. The vision screening programme was implemented nationally in 2000, 
with the content being decided upon by a general screening committee in collaboration with 
the Strabismus Association and other organisations specific to regions, such as the Conselleria 
Sanitat in Valencia. 
The vision screening programme has been changed since its start date, specifically in 1992 it 
was extended to include screening in primary care. It has not changed since 1999. There are 
regional general health screening guidelines for vision screening. The vision screening 
programme is reviewed when circumstances arise that indicate the need. The revisions are 
decided upon and funded by the Conselleria Salut, which is a governmental department for 
health that provides funds for screening.  Decisions on revisions are made following meetings 
with experts, including paediatricians, paediatric nurses and ophthalmologist.  
There are no methods for quality monitoring imposed by the government and there has been 
no research concerning the vision screening programme in Spain. Therefore, there is no data 
to determine the exact differences between vision screening in larger city regions and rural 
areas of Spain. 
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5 Screening programme  
The target conditions screened for in Spain are retinopathy of prematurity (ROP), congenital 
eye disorders and reduced visual acuity. The health care professionals delivering vision 
screening, venue for screening and tests used vary depending on the age of the child. Specific 
details of the screening offered within each age group are described more fully in sections 5.1 
to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by an ophthalmologist and a 
paediatrician in hospital, and then an outpatient clinic. The tests conducted at this age include 
eye inspection, red reflex testing, eye motility, retinal examination and pupillary reflexes. In 
preterm babies, the paediatrician conducts the pupillary reflexes and ophthalmologist 
conducts all the other tests. Referral is necessary if there is presence of white pupil or no 
reflex, as well as any other ocular anomaly.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by a paediatrician at child 
healthcare centres (public health centre) or private clinics. The tests conducted at this age 
include eye inspection, red reflex testing, eye motility and pupillary reflexes. These tests are 
conducted every month up to 3 months of age. Babies are referred to an ophthalmologist 
after two abnormal test results, but they are not referred for any inconclusive results unless 
there is suspicion of pathology. Referral is necessary if there is presence of white pupil or no 
reflex, as well as any other ocular anomaly. 
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months of age are screened by a paediatrician in either a public health 
centre or a private clinic, depending on whether parents opt for private or public screening. 
The tests conducted at this age include eye inspection, fixation, red reflex testing, eye 
motility, Hirschberg test, pupillary reflexes and cover test. Children are referred to an 
ophthalmologist after two abnormal test results, but they are not referred for any 
inconclusive results unless there is suspicion of pathology. Referral is necessary if there is 
presence of white pupil, no red reflex, if the child fails the Hirschberg test and if there is any 
other ocular anomaly including suspicion of intermittent or manifest strabismus at 6 months 
of age. 
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months up to 7 years of age are screened by either a nurse, optometrist, or 
a paediatrician in an external office. Screening can be conducted once per year, but usually it 
is carried out at 4 years and 6 years of age. The tests conducted include eye inspection, 
fixation, red reflex testing, eye motility, pursuit movements, pupillary reflexes, cover test, 
alternating cover test, colour vision (sometimes, not always) and visual acuity measurement. 
Children are referred to an ophthalmologist after one abnormal test result. They are not 
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referred for any inconclusive results unless there is suspicion of pathology. Referral is 
necessary if there is presence of white pupil, no reflex, if there is presence of reduced vision 
and if there is any other ocular anomaly. Visual acuity screening takes place for the first time 
at 4 years of age. Visual acuity is measured again at 6 years of age, and then again between 
11 and 14 years old. The optotype charts utilised include, most commonly Pigassou chart and 
Snellen, but Amsterdam picture chart and in some cases Lea Charts are used. The referral 
criteria include: 
x < 0.5decimal (0.3 logMAR, 6/12 Snellen)  at less than 4 years  
x < 0.8 decimal (0.1 logMAR, 6/7.5 Snellen) at age 4 years or more  
x < 1.0 decimal (0.0 logMAR, 6/6 Snellen) and a difference in visual acuity of less than 
0.1 decimal at 7 years or above.  
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist Nurse Optometrist 
Preterm babies  9 9 × × 
0 to 3 months  9 × × × 
3 to 36 months  9 × × × 
3 to 7 years  9 × 9 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 EI Fix RR EM RE Hir PM PR CT ACT CV VA 
Preterm 
babies  
9 × 9 9 9 × × 9 × × × × 
0 to 3 months  9 × 9 9 × × × 9 × × × × 
3 to 36 
months  
9 9 9 9 × 9 × 9 9 × × × 
3 to 7 years  9 9 9 9 × × 9 9 9 9 9 9 
 
Key: EI: Eye inspection; Fix: Fixation; RR: Red reflex testing; EM: Eye motility; RE: Retinal examination; Hir: Hirschberg; PM: Pursuit movements; PR: Pupillary 
reflexes; CT: Cover Test; ACT: Alternating cover test; CV: Colour vision; VA: Visual acuity measurement 
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Outpatient clinic Public health centre Private clinic External office 
Preterm babies  9 9 × × × 
0 to 3 months  × × 9 9 × 
3 to 36 months  × × 9 9 × 
3 to 7 years  × × × × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. No 
automated vision screening is conducted in Spain as part of general vision screening. It is used 
in rare circumstances in private healthcare centres using either Retinomax, PlusOptix, or 
Welch Allyn. The exact number of private healthcare centres using these devices is not known. 
When they are used, it is conducted in collaboration with a visual acuity test. To date there 
are no official referral criteria. There is no official protocol outlining whether a child is referred 
if they pass the visual acuity, but fail the PlusOptix. There is no comparative data between 
places that do and do not conduct automated screening.  
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7 Provision for Visually Impaired  
There are no schools for blind or severely visually impaired children in Spain. Instead, these 
children attend regular mainstream primary school and have support from the Blind 
Association known as ONCE. The costs per child for these schools is not known. In 2014, it was 
estimated that 99% of blind or visually impaired children attended regular mainstream school 
(europapress.es, 2018). The ONCE organisation provide personal teachers to schools that 
assess every blind or visual impaired child and their needs (different depending on the type 
of impairment). These teachers provide adapted books, visual aids and many new 
technological items that are specifically adapted for blind children. 
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
No data available.  
8.2 Coverage 
No data available.  
8.3 Screening evaluation 
No data available.  
8.4 Treatment success 
Ophthalmologists, and sometimes optometrists, are the only professional who prescribe 
glasses for children under the age of 7 years. Other treatment options include patching, 
atropine and cataract surgery where appropriate. All eligible children are treated.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
No data available.  
9.2 Cost of treatment for amblyopia 
No data available.  
9.3 Cost of Treatment for strabismus  
No data available.  
9.4 Cost of treatment for cataract 
No data available.  
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